Skip to main menu Skip to main content Skip to footer
Home / About Us / Clinical Trials

Clinical Trials

The Retina Institute of Virginia is an active participant in national research trials. The tireless efforts of our patients and staff have led to the approval of many treatments now considered to be standard of care. Our continuing efforts and involvement in clinical research will lead to superior treatments to ultimately preserve sight.

Please call (804) 644-7478 for more information and participation criteria in our active clinical trials.

Clinical Research

Current Trials

A Randomized, Partially Masked, Controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants with nAMD.

A Randomized, Double-Masked, Multicenter, 3-Arm Pivotal Phase 2/3 Study to Evaluate the Efficacy and Safety of Intravitreal EYE103 Compared with Intravitreal Ranibizumab (0.5mg) in Participants with Diabetic Macular Edema.

A Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination with Aflibercept or Faricimab in Patients with Diabetic Macular Edema.

Please call 804 644 7478 for more information and participation criteria in our active clinical trials.

⇧